Table 2 Supply, equipment and drug for early detection and management of pre-eclampsia/eclampsia (PE/E) available at the point of care
Available items number (%) | Facility type | ||||||
|---|---|---|---|---|---|---|---|
SHa, RHb, PHc (n = 37) | High Volume DHd (5 or more deliveries per day) (n = 40) | Low Volume DHd and CHCe (0–4 deliveries per day) (n = 37) | BHCf, SHCg, hFHH (n = 112) | p-value | All public sector (n = 226) | Private hospitals (n = 20) | |
Guidelines or national treatment protocol for emergency obstetric and newborn care | 16 (43.2%) | 19 (47.5%) | 20 (54.1%) | 47 (42.0%) | 0.527 | 102 (45.1%) | 7 (35.0%) |
Functioning blood pressure apparatusi | 30 (81.1%) | 34 (85.0%) | 35 (94.6%) | 95 (84.8%) | 0.303 | 194 (85.8%) | 15 (75.0%) |
Functioning stethoscope | 29 (78.4%) | 36 (90.0%) | 35 (94.6%) | 99 (88.4%) | 0.702 | 199 (88.1%) | 17(85.0%) |
Functioning fetal stethoscope or fetoscope | 25 (67.6%) | 36 (90.0%) | 34 (91.9%) | 99 (88.4%) | 0.094 | 194 (85.8%) | 15 (75.0%) |
Injectable oxytocin | 33 (89.2%) | 36 (90.0%) | 36 (97.3%) | 94 (83.9%) | 0.637 | 199 (88.1%) | 18 (90.0%) |
Misoprostol | 21 (56.8%) | 21 (52.5%) | 5 (13.5%) | 10 (8.9%) | < 0.001 | 57 (25.2%) | 12 (60.0%) |
Injectable diazepam | 28 (75.7%) | 29 (72.5%) | 25 (67.6%) | 49 (43.8%) | < 0.001 | 131 (58.0%) | 11 (55.0%) |
Injectable magnesium sulfate | 33 (89.2%) | 36 (90.0%) | 28 (75.7%) | 81 (72.3%) | 0.370 | 178 (78.8%) | 18 (90.0%) |
Injectable calcium gluconate | 31 (83.8%) | 32 (80.0%) | 11 (29.7%) | 39 (34.82%) | < 0.001 | 113 (50.0%) | 15 (75.0%) |